www.engrail.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $221MM
Engrail Therapeutics is a pharmaceutical company that aims to develop treatments for neuropsychiatric and neurodevelopmental disorders that have unmet needs, which include anxiety disorder, depression, and post-traumatic stress disorder. The company strives to use precision-targeted therapies that act on specific parts of the nervous system involved in the disease process with the goal of maximizing effectiveness and minimizing side effects. Engrail Therapeutics was founded in 2019 and is headquartered in San Diego, California.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Engrail Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.